FMP
co.don AG
CNW.DE
XETRA
Inactive Equity
co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
0.245 EUR
0 (0%)
About
ceo
Dr. Xing Zhao
sector
Healthcare
industry
Biotechnology
website
https://www.codon.de
exchange
XETRA
Description
co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
CIK
N/A
ISIN
N/A
CUSIP
N/A
Address
Warthestraße 21
Phone
49 3328 43 46 0
Country
DE
Employee
134
IPO Date
Feb 14, 2001
Summary
CIK
-
Exchange
XETRA
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
-
Country
DE
Price
0.24
Beta
1.75
Volume Avg.
8.01k
Market Cap
6.55M
Shares
-
52-Week
0.245-2.35
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.44
P/B
-
Website
https://www.codon.de
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CNW.DE News
It looks like there's no news available.
